GLAXF

 
Ordinary Shares SEC Reporting - Current
Pink Current Information
Contact Info
  • 980 Great West Road
  • Brentford
  • Middlesex TW8 9GS
  • United Kingdom

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 20-F
CIK 0001131399
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: United Kingdom
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Jean-Pierre Garnier CEO
John Coombe CFO
Simon Bicknell Secretary
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Formerly=Glaxo Wellcome plc until 12-00. Glaxo Wellcome plc merged with SmithKline Beecham plc. prior to name change. Basis: 1.138 GlaxoSmithKline plc ADRs for each SmithKline Beecham plc ADR held
  • Formerly=Glaxo, PLC until 5-95
GLAXF Security Details Other Company Securities
Share Structure
Market Value1 $109,824,970,500 a/o May 22, 2017
Authorized Shares Not Available
Outstanding Shares 5,192,670,000 a/o Jun 30, 2010
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
GSK - LSE - London Stock Exchange - Qualified
Short Selling Data
Short Interest 464,477 (4.5%)
Apr 28, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security